Cure My Disease

Don't miss your cure!

 Log in / Sign up

Laser zaps brain tumor regrowth without delaying key therapy

NCT ID NCT07616986

Recruiting now Disease control Sponsor: Insel Gruppe AG, University Hospital Bern Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a minimally invasive laser treatment for glioblastoma that regrows shortly after initial surgery, before standard radiotherapy and chemotherapy begin. The goal is to see if the laser can safely treat the regrowth without delaying the planned follow-up treatments. Only 12 adults with glioblastoma will participate, and the main focus is on whether the treatment schedule can be maintained.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Laser interstitial thermal therapy (LITT) - a minimally invasive procedure using heat from a laser to destroy tumor tissue
What this could lead to
If successful, this could offer a way to treat early glioblastoma regrowth without delaying standard radiotherapy and chemotherapy, potentially improving survival.
What could go wrong
This is a very small, early feasibility study with only 12 participants. The procedure carries risks like bleeding, infection, or brain swelling, and it may not improve outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA (GBM) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glioblastoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GLIOBLASTOMA (GBM) GLIOBLASTOMA - CATEGORY

Contacts and locations

Locations

  • Dep. of Neurosurgery, Bern University Hospital

    RECRUITING

    Bern, 3010, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.